However, it remains unknown if IGF2BP1 is an oncogene in human cancers, how it synergizes with MYCN in neuroblastoma and if the targeting of IGF2BP1 harbors therapeutic benefits in cancer treatment. The gene discussed is IGF2BP1; the disease is cancer.